Abstract
Objective
To examine the measurement properties of and comparability between the English and Chinese versions of the five-level EuroQoL Group’s five-dimension questionnaire (EQ-5D) in breast cancer patients in Singapore.
Methods
This is an observational study of 269 patients. Known-group validity and responsiveness of the EQ-5D utility index and visual analog scale (VAS) were assessed in relation to various clinical characteristics and longitudinal change in performance status, respectively. Convergent and divergent validity was examined by correlation coefficients between the EQ-5D and a breast cancer-specific instrument. Test–retest reliability was evaluated. The two language versions were compared by multiple regression analyses.
Results
For both English and Chinese versions, the EQ-5D utility index and VAS demonstrated known-group validity and convergent and divergent validity, and presented sufficient test–retest reliability (intraclass correlation = 0.72 to 0.83). The English version was responsive to changes in performance status. The Chinese version was responsive to decline in performance status, but there was no conclusive evidence about its responsiveness to improvement in performance status. In the comparison analyses of the utility index and VAS between the two language versions, borderline results were obtained, and equivalence cannot be definitely confirmed.
Conclusion
The five-level EQ-5D is valid, responsive, and reliable in assessing health outcome of breast cancer patients. The English and Chinese versions provide comparable measurement results.
Similar content being viewed by others
References
Axelsson B, Sjoden PO (1999) Assessment of quality of life in palliative care: psychometric properties of a short questionnaire. Acta Oncol 38:229–237
Ballatori E (2001) Unsolved problems in evaluating the quality of life of cancer patients. Ann Oncol 12(Suppl 3):S11–S13
Kopec JA, Willison KD (2003) A comparative review of four preference-weighted measures of health-related quality of life. J Clin Epidemiol 56:317–325
Barton GR, Sach TH, Jenkinson C et al (2008) Do estimates of cost-utility based on the EQ-5D differ from those based on the mapping of utility scores? Health Qual Life Outcomes 6:51
Janssen MF, Birnie E, Haagsma JA, Bonsel GJ (2008) Comparing the standard EQ-5D three-level system with a five-level version. Value Health 11:275–284
Janssen MF, Birnie E, Bonsel GJ (2008) Quantification of the level descriptors for the standard EQ-5D three-level system and a five-level version according to two methods. Qual Life Res 17:463–473
Herdman M, Gudex C, Lloyd A, et al. (2011) Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 20:1727–1736
Sullivan PW, Ghushchyan V (2006) Preference-based EQ-5D index scores for chronic conditions in the United States. Med Decis Making 26:410–420
Gao F, Ng GY, Cheung YB et al (2009) The Singaporean English and Chinese versions of the EQ-5D achieved measurement equivalence in cancer patients. J Clin Epidemiol 62:206–213
Graddol D (2004) The future of language. Science 303:1329–1331
Brady M, Cella D, Mo F et al (1997) Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clinic Oncol 15:974–986
Wan C, Zhang D, Yang Z et al (2007) Validation of the simplified Chinese version of the FACT-B for measuring quality of life for patients with breast cancer. Breast Cancer Res Treat 106:413–418
Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655
Cheung YB, Goh C, Thumboo J et al (2005) Variability and sample size requirements of quality-of-life measures: a randomized study of three major questionnaires. JCO 23:4936–4944
Blagden SP, Charman SC, Sharples LD et al (2003) Performance status score: do patients and their oncologists agree? Br J Cancer 89:1022–1027
Pickard AS, Kohlmann T, Janssen MF et al (2007) Evaluating equivalency between response systems application of the Rasch model to a 3-level and 5-level EQ-5D. Med Care 45:812–819
Luo N, Li MH, Liu GG, Lloyd A, de Charro F, Herdman M (2012) Developing the Chinese version of the new 5-level EQ-5D descriptive system: the response scaling approach. Qual Life Res. doi:10.1007/s11136-012-0200-0
Rabin R, Oemar M, Oppe M, et al. (2011) EQ-5D-5L user guide: basic information on how to use the EQ-5D-5L instrument. EuroQoL Group. Available at http://www.euroqol.org/fileadmin/user_upload/Documenten/PDF/Folders_Flyers/UserGuide_EQ-5D-5L.pdf; assessed 2 Jul 2011
Tsuchiya A, Ikeda S, Ikegami N et al (2002) Estimating an EQ-5D population value set: the case of Japan. Health Econ 11:341–353
Ng R, Lee CF, Wong NS, et al. (2012) Measurement properties of the English and Chinese versions of the Functional Assessment of Cancer Therapy-Breast (FACT-B) in Asian breast cancer patients. Breast Cancer Res Treat 131:619–625
Cella D (1997) FACIT Manual: manual of the functional assessment of chronic illness therapy (FACIT) measurement system. Evanston, IL, CORE
Cuzick JA (1985) Wilcoxon-type test for trend. Stat Med 4:87–90
Senn S (1997) Statistical issues in drug development. Chichester, UK: Wiley; 320
Cheung YB, Thumboo J, Goh C et al (2004) The equivalence and difference between the English and Chinese versions of two major cancer-specific health-related quality of life questionnaires. Cancer 101:2874–2880
Cheung YB (2007) A modified least-squares regression approach to the estimation of risk difference. Am J Epidemiol 166:1337–1344
Luo N, Chew LH, Fong KY et al (2003) Do English and Chinese EQ-5D versions demonstrate measurement equivalence? Health Qual Life Outcomes 1:7
McNamee R (2005) Regression modelling and other methods to control confounding. Occup Environ Med 62:500–506
Pickard AS, De Leon MC, Kohlmann T et al (2007) Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients. Med Care 45:259–263
Mehta CR, Patel NR (1983) A network algorithm for performing Fisher's exact test in r × c contingency tables. JASA 78:427–434
Acknowledgment
The study was funded by National Medical Research Council, Singapore (NMRC/EDG/0063/2009).
Conflict of interest
We declare that we have no potential conflict of interest, and this manuscript has not been published and is not under consideration for publication elsewhere. We have full control of all primary data, and we agree to allow the Journal of Supportive Care in Cancer to review the data if requested.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, C.F., Ng, R., Luo, N. et al. The English and Chinese versions of the five-level EuroQoL Group's five-dimension questionnaire (EQ-5D) were valid and reliable and provided comparable scores in Asian breast cancer patients. Support Care Cancer 21, 201–209 (2013). https://doi.org/10.1007/s00520-012-1512-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-012-1512-x